Regardless of other factors, the mortality rate continued to increase statistically, to 4,591 times in patients with primary tumor Akt > 57.5 compared with those with CRC tumor Akt ≤ 57.5 (p = 0.007). The gene discussed is AKT1; the disease is neoplasm.